SB 4626, the “Protecting Enlisted and Recruits from Excessive and Catastrophic Trials Act of 2026” or “PERFECT Act of 2026,” would require the Secretary of Defense to publish and update at least every 90 days a public list of dietary supplement ingredients and performance-enhancing substances prohibited for use by members of the Armed Forces. The list would have to be available in multiple formats, including a full website view, searchable database, and downloadable file. The bill also directs the Department of Defense to improve its Operation Supplement Safety website, consider better search tools and AI-based label scanning, and create notification features for newly added prohibited ingredients.
The bill would also change how the military handles service members who possess or use supplements containing listed ingredients. For a first offense, a commanding officer could choose not to impose discipline or administrative separation if the member acted in good faith and agrees to education, counseling, or drug testing. The bill further states that possession of a supplement containing a listed ingredient, by itself, would not count as drug abuse under title 10, unless the ingredient is a controlled substance under the Controlled Substances Act. The Secretary of Defense would also have to revise implementing guidance within 120 days and report to Congress on implementation, retail compliance, and annual disciplinary and education outcomes.
The bill’s impact would be on federal military law and Department of Defense policy, especially title 10 of the U.S. Code and DoD Instruction 6130.06. It would create a new statutory framework for identifying prohibited supplement ingredients, require ongoing public disclosure and database maintenance, and impose reporting obligations on the Pentagon. It would also affect service members, commanders, military recruiters and trainees, and DoD-affiliated retail facilities that sell dietary supplements.
No committee transcript or vote record is provided, so there is no documented debate or recorded sentiment in the materials supplied. Based on the bill text alone, the measure appears aimed at protecting service members from inadvertent violations and improving transparency and education, while still preserving command authority over prohibited substances. The inclusion of good-faith protections and reporting requirements suggests a compliance-focused approach rather than a punitive one.
Potential points of contention include whether the prohibited-ingredient list will be accurate and easy to use, how broadly the military should restrict supplements, and whether commanders should retain discretion to avoid discipline or separation for first-time, good-faith violations. There may also be concern about the administrative burden on the Department of Defense, the reliability of supplement labeling and search tools, and the extent to which the bill could limit enforcement against performance-enhancing or risky products.
The bill would amend title 10, United States Code, by adding a new section requiring the Department of Defense to maintain a public, frequently updated list of prohibited dietary supplement ingredients and performance-enhancing substances. It would also require updates to DoD guidance, improvements to the Operation Supplement Safety website, training on supplement safety, and multiple implementation reports to Congress. The measure would affect military disciplinary and separation processes by allowing commanders to forgo punishment in certain first-offense, good-faith cases and by clarifying that possession of a supplement containing a listed ingredient is not automatically drug abuse under military law.
No votes or committee discussion are included, so there is no formal record of support or opposition in the provided materials. The bill’s structure suggests a generally protective and administrative intent, emphasizing transparency, education, and fair treatment of service members who may unknowingly use prohibited supplements. At the same time, it preserves enforcement authority, indicating an effort to balance readiness and discipline with due process and consumer-safety concerns.
The main likely areas of contention are the scope and accuracy of the prohibited-ingredient list, the burden on the Department of Defense to keep the list current and searchable, and the extent of commander discretion in waiving discipline or separation. Critics could question whether the good-faith standard is too broad or too vague, while supporters may argue it is necessary to avoid punishing service members for mislabeled or hard-to-identify supplements. Another possible dispute is whether the bill goes far enough in preventing unsafe supplement use or whether it risks undercutting military readiness and anti-doping enforcement.